Fresenius Medical Care AG (FMS) Receivables - Other (2009 - 2026)

Fresenius Medical Care AG's Receivables - Other history runs 18 years deep, the most recent figure standing at $34.5 million for Q1 2026.

• In Q1 2026, Receivables - Other rose 21.49% year-over-year to $34.5 million; the TTM figure through Mar 2026 stood at $34.5 million (up 21.49% YoY), while the FY2025 annual figure was $38.0 million, down 67.32% from the prior year.
• Receivables - Other for Q1 2026 stood at $34.5 million, down from $38.0 million in the prior quarter.
• The five-year high for Receivables - Other was $250.5 million in Q4 2023, with the low at $28.4 million in Q1 2025.
• The 5-year median for Receivables - Other is $116.4 million (2024), against an average of $115.2 million.
• The sharpest annual moves came in 2024 and 2025: Receivables - Other surged 46.93% in 2024, then slumped 77.52% in 2025.
• Fresenius Medical Care AG's Receivables - Other stood at $202.6 million in 2022, then advanced by 23.68% to $250.5 million in 2023, then sank by 53.54% to $116.4 million in 2024, then sank by 67.32% to $38.0 million in 2025, then decreased by 9.23% to $34.5 million in 2026.
• Business Quant data shows FMS's Receivables - Other at $34.5 million in Q1 2026, $38.0 million in Q4 2025, and $38.6 million in Q3 2025.